DEA Considers Bulk Manufacturing of Psilocybin for Science
Published Date: 12/3/2025
Notice
Summary
Kinetochem LLC wants to become a big-time maker of some powerful controlled substances like marijuana and psilocybin for research and medicine. People and companies involved with these drugs can share their thoughts or ask for a hearing by February 2, 2026. This move could speed up scientific studies and drug development, with no direct cost changes announced yet.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
New Schedule I API supplier seeks registration
On October 15, 2025 Kinetochem LLC applied to be registered as a bulk manufacturer of Schedule I controlled substances including Marihuana (code 7360), Tetrahydrocannabinols (7370), Psilocybin (7437), and Psilocyn (7438). The company says it plans to bulk manufacture these drugs as Active Pharmaceutical Ingredients (APIs) for its customers and for research and clinical trials.
Synthetic-only manufacture for marijuana and THC
For drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols), Kinetochem plans to bulk manufacture these drugs as synthetic only, and the notice states that no other activities for these drug codes are authorized for this registration.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in